Giuseppina Cantarella
Overview
Explore the profile of Giuseppina Cantarella including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
1322
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cantone A, Burgaletto C, Di Benedetto G, Gaudio G, Giallongo C, Caltabiano R, et al.
J Neuroimmune Pharmacol
. 2025 Feb;
20(1):15.
PMID: 39918606
Alzheimer's disease (AD) is the most common cause of dementia worldwide, characterized by accumulation of amyloid-β protein and hyperphosphorylated tau protein in the brain. Neuroinflammation, resulting from chronic activation of...
2.
Musumeci T, Di Benedetto G, Carbone C, Bonaccorso A, Amato G, Lo Faro M, et al.
Biomedicines
. 2024 Nov;
12(11).
PMID: 39595214
Figure 5 in the original publication [...].
3.
Cuocina M, Aiello G, Cutrufelli P, Rampello M, Rapisarda L, Rodolico A, et al.
Front Pharmacol
. 2024 Sep;
15:1462612.
PMID: 39309000
Background: N-acetyl cysteine (NAC) appears promising as a treatment in patients with substance use disorder (SUD) as it helps rebalance glutamate levels in the central nervous system (CNS). Basal concentrations...
4.
Marino A, Augello E, Stracquadanio S, Bellanca C, Cosentino F, Spampinato S, et al.
Int J Mol Sci
. 2024 Jul;
25(13).
PMID: 38999924
represents a significant concern in nosocomial settings, particularly in critically ill patients who are forced to remain in hospital for extended periods. The challenge of managing and preventing this organism...
5.
Immune responses to oligomeric α-synuclein in Parkinson's disease peripheral blood mononuclear cells
Vega-Benedetti A, Porcedda C, Ercoli T, Fusco G, Burgaletto C, Pillai R, et al.
J Neurol
. 2024 Jul;
271(9):5916-5929.
PMID: 38985290
Parkinson's disease displays clinical heterogeneity, presenting with motor and non-motor symptoms. Heterogeneous phenotypes, named brain-first and body-first, may reflect distinct α-synuclein pathology starting either in the central nervous system or...
6.
Bellanca C, Augello E, Di Benedetto G, Burgaletto C, Cantone A, Cantarella G, et al.
Front Pharmacol
. 2024 Jul;
15:1406860.
PMID: 38957391
Currently 1.3 billion individuals globally engage in smoking, leading to significant morbidity and mortality, particularly among diabetic patients. There is urgent need for a better understanding of how smoking influences...
7.
Bracciama E, Sapuppo A, Rapisarda L, Siciliano E, Caciotti A, Morrone A, et al.
Curr Issues Mol Biol
. 2024 Jun;
46(6):6112-6120.
PMID: 38921036
Wilson's disease (WD) is a biallelic disease-causing variant in the gene on chromosome 13q14.3 that results in copper accumulation in many organs, particularly the liver and brain. The phenotypic spectrum...
8.
Munafo A, Cantone A, Di Benedetto G, Torrisi S, Burgaletto C, Bellanca C, et al.
Front Pharmacol
. 2024 Apr;
15:1386224.
PMID: 38595916
Alzheimer's disease (AD) is the most common neurodegenerative disorder affecting the elderly population worldwide. Due to the multifactorial nature of the disease, involving impairment of cholinergic neurotransmission and immune system,...
9.
Cantone A, Burgaletto C, Di Benedetto G, Pannaccione A, Secondo A, Bellanca C, et al.
Cells
. 2024 Feb;
13(4.
PMID: 38391922
Alzheimer's disease (AD), marked by cognitive impairment, predominantly affects the brain regions regulated by cholinergic innervation, such as the cerebral cortex and hippocampus. Cholinergic dysfunction, a key contributor to age-related...
10.
Bellanca C, Augello E, Mariottini A, Bonaventura G, La Cognata V, Di Benedetto G, et al.
Curr Neuropharmacol
. 2024 Jan;
22(8):1286-1326.
PMID: 38275058
Multiple sclerosis (MS) is the most prevalent chronic autoimmune inflammatory- demyelinating disorder of the central nervous system (CNS). It usually begins in young adulthood, mainly between the second and fourth...